📌 Key Takeaways
- Topic: Silica as a Rheology Modifier: How It Controls Viscosity and Flow
- Keywords: silicon carbide
- Published: 2026-11-20 04:39:49
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
How to Request a Silica Quote: Information Suppliers Need for Accurate Pricing
- What Is Quartz Powder? Production, Particle Sizes, Purity Grades and Uses
- 19. Zhao Y., Wang Y., Ran F., Cui Y., Liu C., Zhao Q., Gao Y., Wang D., Wang S. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci. Rep. 2017;7:4131. doi: 10.1038/s41598-017-03834-2. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Spherical Silica Market 2026: Semiconductor Packaging Demand and Growth Outlook
- 61. Tzankov B., Voycheva C., Tosheva A., Stefanova D., Tzankova V., Spassova I., Kovacheva D., Avramova K., Tzankova D., Yoncheva K. Novel oleogels for topical delivery of quercetin based on mesoporous silica MCM-41 and HMS particles. J. Drug Deliv. Sci. Technol. 2023;86:104727. doi: 10.1016/j.jddst.2023.104727. [ DOI ] [ Google Scholar ]
- Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria
- Silica Supply Chain: Raw Materials, Production Hubs and Risks
Silica as a Carrier: Converting Liquids into Free-Flowing Powders
What is silica (SiO₂)?
silica supplier Mexico 78. Guo X., Zhang C., Bai Y., Che Q., Cao H., Guo J., Su Z. Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury. Molecules. 2023;28:4147. doi: 10.3390/molecules28104147. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
silica powder One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
What drives silica raw material prices?
E551 73. Manzano M., Vallet-Regí M. Mesoporous silica nanoparticles in nanomedicine applications. J. Mater. Sci. Mater. Med. 2018;29:65. doi: 10.1007/s10856-018-6069-x. [ DOI ] [ PubMed ] [ Google Scholar ]
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.